1. Home
  2. POLA vs KZIA Comparison

POLA vs KZIA Comparison

Compare POLA & KZIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Polar Power Inc.

POLA

Polar Power Inc.

HOLD

Current Price

$2.23

Market Cap

6.0M

Sector

Miscellaneous

ML Signal

HOLD

Logo Kazia Therapeutics Limited

KZIA

Kazia Therapeutics Limited

HOLD

Current Price

$10.59

Market Cap

161.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
POLA
KZIA
Founded
1979
1994
Country
United States
Australia
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.0M
161.5M
IPO Year
2016
1999

Fundamental Metrics

Financial Performance
Metric
POLA
KZIA
Price
$2.23
$10.59
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$17.67
AVG Volume (30 Days)
21.5K
2.0M
Earning Date
11-19-2025
12-26-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$8,326,000.00
$1,199,108.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.53
$2.86
52 Week High
$5.75
$21.00

Technical Indicators

Market Signals
Indicator
POLA
KZIA
Relative Strength Index (RSI) 35.74 51.53
Support Level $2.15 $11.75
Resistance Level $2.35 $17.40
Average True Range (ATR) 0.13 2.71
MACD 0.04 0.07
Stochastic Oscillator 37.14 35.08

Price Performance

Historical Comparison
POLA
KZIA

About POLA Polar Power Inc.

Polar Power Inc is engaged in designing, manufacturing, and selling DC power generators, renewable energy, and cooling systems for applications in the telecommunications market and, to a lesser extent, in other markets, including military, electric vehicle, marine, and industrial. The company's products include DC generators, backup DC generators, hybrid power systems, Li-Ion battery systems, Marine DC generators, and others. The company's geographical presence is in the United States, Canada, Australia and South Pacific Islands, Asia, Europe and Middle East, United Kingdom, Other North America, South Africa, and others.

About KZIA Kazia Therapeutics Limited

Kazia Therapeutics Ltd is a biotechnology company focused on pharmaceutical drug development in oncology. The company has a portfolio of development candidates across various technologies targeting multiple cancer indications. Its primary program is Paxalisib, an investigational brain-penetrant inhibitor of the PI3K/Akt/mTOR pathway, designed for the treatment of brain cancer. The company develops targeted therapies aimed at addressing medical needs in oncology. The company operates in Australia and the United States.

Share on Social Networks: